Target intelligence / Profile preview

RING-box protein 1 (RBX1)

Target
RBX1
Molecular classification
Enzyme, E3 ubiquitin ligase, RING-finger protein
01

Overview

RING-box protein 1 (RBX1) is a **conserved E3 ubiquitin ligase component** encoded by the RBX1 gene in humans[1][4]. It is an essential part of the Skp1–Cullin–F-box (SCF) complex (Cullin–RING ligase family), facilitating the transfer of ubiquitin from E2 enzymes to target proteins, thereby marking them for proteasome-mediated degradation[1][4]. RBX1 heterodimerizes with cullin proteins (CUL1, 2, 4A, 5, and 7), forming the catalytic core of E3 ligases involved in regulating protein turnover, cell cycle progression, and genomic stability[1][2][4]. RBX1 activity is critical for normal development, cell division, and cancer cell proliferation; its dysfunction or suppression leads to cell cycle arrest, DNA damage, apoptosis, and developmental lethality in model organisms[2][4]. It is also referred to as ROC1 or Regulator of Cullin 1. Targeting RBX1 or the SCF E3 ligase complex has therapeutic research interest in oncology, but broad inhibition may have significant safety challenges due to RBX1’s fundamental role in cellular homeostasis[4].

Other names
Regulator of cullin 1ROC1Rbx1
02

Mechanism of action

Inhibition of SCF (Skp1–Cullin–F-box) E3 ligase activity, Promotion of substrate degradation via the ubiquitin–proteasome pathway

03

Biological functions

UbiquitinationRegulation of protein degradationCell cycleGenome integrityCell proliferationApoptosis
04

Disease associations

CancerGenomic instabilityDevelopmental disorders
05

Safety considerations

Global inhibition may affect normal cell cycle and developmentrisk of genomic instabilityapoptosisembryonic lethality
06

Interacting drugs

None established as approved drugs specifically targeting RBX1; E3 ligase inhibitors (such as cullin neddylation inhibitors) under investigation
07

Biomarkers

Genomic instability markersCell cycle proteins (e.g., CDT1, ORC1) that accumulate upon RBX1 suppression

Beyond the preview

Go deeper on RING-box protein 1 (RBX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RING-box protein 1 (RBX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call